Vaxart to Present at World Vaccine Congress Europe 2022 on October 13
SOUTH SAN FRANCISCO, Calif., Oct. 10, 2022 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today…
Month: October 2022
scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide injection), the First and Only Self-administered, Subcutaneous Loop Diuretic for the At-home Treatment of Congestion in Chronic Heart Failure
FUROSCIX demonstrated 99.6% bioavailability and produced similar diuresis and natriuresis compared to intravenous furosemide Commercial…
Immatics Announces $110 Million Underwritten Offering of Ordinary Shares
Houston, Texas and Tuebingen, Germany, October 10, 2022 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a…
Immatics Reports Interim Clinical Data Update on ACTengine® IMA203 TCR-T Monotherapy Targeting PRAME
Company to host conference call today, October 10, at 8:30 am EDT / 2:30 pm…
BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference
POMPANO BEACH, FLORIDA., Oct. 10, 2022 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC PINK: BSEM),…
Iovance Biotherapeutics Announces First Patient Dosed with PD-1 Inactivated Tumor Infiltrating Lymphocyte (TIL) Therapy
First Genetically Modified (TALEN®-edited) Iovance TIL Therapy with Inactivated PD-1 Expression SAN CARLOS, Calif., Oct….
First Wave BioPharma Presents Research Demonstrating Benefits of Improved Adrulipase Drug Delivery Formulation at AAPS 2022 PharmSci 360
Poster presentation indicates new microgranule formulation elicited desired delayed release profile, offering protection at acidic…
Zynerba Pharmaceuticals Announces Poster Presentation at the National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit
DEVON, Pa., Oct. 10, 2022 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
Orchard Announces Multiple Presentations at 2022 ESGCT Annual Congress Showing the Potential of HSC Gene Therapy in Several Therapeutic Areas
Clinical and pre-clinical data from across the company’s portfolio will be featured in four oral…
G1 Therapeutics Completes Enrollment in Global Multi-Center Phase 3 Clinical Trial of Trilaciclib in Patients with Metastatic Triple Negative Breast Cancer (TNBC)
RESEARCH TRIANGLE PARK, N.C., Oct. 10, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage…
WonderFi’s Ben Samaroo and Kevin O’Leary to Speak at the W3BX Investor Summit
Vancouver, British Columbia–(Newsfile Corp. – October 10, 2022) – WonderFi Technologies Inc. (TSX: WNDR) (OTCQB: WONDF)…
Investment Banker Deal Origination & Sourcing Platform Announced By OutFlow
OutFlow has announced an expanded range of deal origination solutions for investment banks, allowing them…
1,450+ Organisation Identified in the UAE Web3 Space as per the Crypto Oasis Ecosystem Report 2022
DUBAI, Oct 10, 2022 – (ACN Newswire) – Crypto Oasis, the fastest growing Web3 ecosystem…
Jackson Nurse Professionals Named a 2022 Top Workplace by Orlando Sentinel
Company recognized on newly-published Top Workplaces list based on associate feedback ORLANDO, Fla.–(BUSINESS WIRE)–Jackson Nurse…
Houlihan Lokey Expands its Cybersecurity Coverage Capabilities
Keith Skirbe Joins as a Managing Director in San Francisco SAN FRANCISCO–(BUSINESS WIRE)–Houlihan Lokey (NYSE:HLI),…
SnapLogic Study Reveals a Third of IT Leaders Have Been Forced to Deprioritize or Cancel Tech Projects
Growing tech pressure as almost 50 percent of IT decision-makers report a demand for integrating…
MEPPI Introduces 72kV Vacuum Circuit Breaker with Dry-Air Insulation
MEPPI’s latest vacuum circuit breaker offers outstanding performance and environmental benefits WARRENDALE, Pa.–(BUSINESS WIRE)–Mitsubishi Electric…
Stellar Cyber Provides Customers with Enhanced Security Operations
Stellar Cyber Open XDR, the Cybersecurity Platform Powered by Oracle Cloud , is Now Available…
Swanson Health Products Chooses Medallia for Customer Experience
PLEASANTON, Calif.–(BUSINESS WIRE)–Medallia, Inc., the global leader in customer and employee experience, today announced that…
SolomonEdwards Announces Leadership Succession Plan
Scott Balestrier has joined the firm as Chief Executive Officer Ed Baumstein moves to Board…